Basics Tevogen Bio Holdings Inc. Common Stock IPO Date: February 15, 2024 Sector: Healthcare Industry: Biotech Market Cap: $232.43M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 6.19% Avg Daily Range (30 D): $0.04 | 2.95% Avg Daily Range (90 D): $0.04 | 3.40% Institutional Daily Volume Avg Daily Volume: 3.17M Avg Daily Volume (30 D): .61M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 311 Avg Trade Size (Sh.) (30 D): 330 Avg Trade Size (Sh.) (90 D): 311 Institutional Trades Total Inst.Trades: 4 Avg Inst. Trade: $.83M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .68M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.86M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 913.51K     News Jul 18, 2025 @ 4:36 PM Tevogen.AI Receives International Patent Publicati... Source: Dr. Ryan Saadi Jul 16, 2025 @ 10:35 PM From Clinics to Cancer Labs, AI Is Unlocking a New... Source: Prnewswire Jun 30, 2025 @ 6:28 PM Tevogen CEO Contributes to Build-Out and First-Yea... Source: Ryan Saadi, M.D., M.P.H. Jun 30, 2025 @ 1:50 PM AI Is Quietly Reinventing Healthcare--And Real Dep... Source: Prnewswire May 5, 2025 @ 4:35 PM AI Healthcare Boom Gains Speed as Regulators and I... Source: Prnewswire Financials   TTM Q4 2024 FY 2024 Basic EPS $-.07 $-.06 $-.07 Diluted EPS $-.07 $-.06 $-.07 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -10.37M $ -9.44M $ -13.73M Operating Income / Loss $ -10.36M $ -9.36M $ -53.56M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio